Vanda Pharmaceuticals, Inc. (VNDA)
7.91
-0.29
(-3.54%)
USD |
NASDAQ |
Mar 05, 16:00
7.93
+0.02
(+0.25%)
After-Hours: 20:00
Vanda Pharmaceuticals Cash from Investing (TTM) : 94.86M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Eli Lilly & Co. | -10.97B |
| Axsome Therapeutics, Inc. | -0.48M |
| AnaptysBio, Inc. | 228.03M |
| Gossamer Bio, Inc. | 136.42M |
| Arcellx, Inc. | 86.30M |